EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Presentation of the protective epitope in a Chlamydia muridarum MOMP vaccine is dependent on γ-interferon-inducible lysosomal thiol reductase (GILT)

Sukumar Pal iD, Raymond M Johnson, Delia F Tifrea, Peter Cresswell, Luis M de la Maza

ImmunoHorizons · 11.04.2026 · 10 (4)

DOI: 10.1093/immhor/vlag018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoHorizons, online erschienen am 16.04.2026. Verfasst von Sukumar Pal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, United States. Hauptthemen laut MEDLINE: Chlamydia muridarum, Chlamydia Infections, Bacterial Vaccines, Oxidoreductases Acting on Sulfur Group Donors. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, Public Health Service, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Chlamydia outer membrane complex has approximately 20 cysteine-rich proteins, including the major outer membrane protein (MOMP) with 8 cysteines. The enzyme γ-interferon-inducible lysosomal thiol reductase (GILT) is expressed constitutively in lysosomes of antigen presenting cells and reproductive tract epithelial cells. GILT catalyzes disulfide bond reduction during protein degradation that generates T cell epitopes. To evaluate the role that GILT plays in chlamydial infections, C57BL/6 WT mice and mice deficient in Ifi30 (GILT-KO) were challenged vaginally with Chlamydia muridarum (Cm). Both were equally susceptible to the Cm infection and upper genital tract pathology. To assess GILT’s role in processing MOMP epitopes, WT and GILT-KO mice were immunized with native (nMOMP) or recombinant (rMOMP) antigens. In both strains vaccination with Cm nMOMP and rMOMP induced a similar spectrum of MOMP-specific antibodies. nMOMP immunization generated higher neutralizing antibody titers than rMOMP, but neutralizing titers did not differ between mouse strains. Splenocytes from vaccinated WT and GILT-KO mice recognized T cell epitopes in nMOMP, and to a lesser extent with rMOMP. No protection was seen in either WT or GILT-KO mice vaccinated with rMOMP based on intensity and duration of vaginal shedding, upper genital tract pathology, and fertility post-infection. nMOMP vaccination protected WT mice based on attenuated bacterial shedding and preserved fertility but nMOMP-vaccinated GILT-KO mice were not protected. The failure of nMOMP vaccination in GILT-KO mice revealed that GILT-dependent MOMP epitope processing was outcome determinative and identified a pan-serovar, likely protective, class II T cell epitope in MOMP constant domain 3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlamydia muridarumChlamydia InfectionsBacterial VaccinesOxidoreductases Acting on Sulfur Group DonorsBacterial Outer Membrane ProteinsAnimalsFemaleMiceMice, Inbred C57BLMice, KnockoutAntibodies, BacterialEpitopes, T-LymphocyteAntibodies, NeutralizingProtein Subunit VaccinesAntigen Presentation

Stichwörter der Autor:innen

Chlamydia vaccineGILT antigen processing and presentationmouse modelnMOMP and rMOMP protective epitope

Substanzen

Bacterial VaccinesOxidoreductases Acting on Sulfur Group DonorsIfi30 protein, mouseBacterial Outer Membrane ProteinsAntibodies, BacterialEpitopes, T-LymphocyteAntibodies, NeutralizingProtein Subunit Vaccines

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, United States.
  • Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
  • Departments of Immunobiology and Cell Biology, Yale University School of Medicine, New Haven, CT, United States.

ORCID-Profile: Sukumar Pal

Förderung

  • NIAID NIH HHS
  • Public Health Service
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Pal, S., Johnson, R. M., Tifrea, D. F., Cresswell, P., & de la Maza, L. M. (2026). Presentation of the protective epitope in a Chlamydia muridarum MOMP vaccine is dependent on γ-interferon-inducible lysosomal thiol reductase (GILT). ImmunoHorizons, 10(4). https://doi.org/10.1093/immhor/vlag018

Vancouver

Pal S, Johnson RM, Tifrea DF, Cresswell P, de la Maza LM. Presentation of the protective epitope in a Chlamydia muridarum MOMP vaccine is dependent on γ-interferon-inducible lysosomal thiol reductase (GILT). ImmunoHorizons. 2026;10(4). doi:10.1093/immhor/vlag018

BibTeX
@article{Pal2026,
  author = {Pal, Sukumar and Johnson, Raymond M and Tifrea, Delia F and Cresswell, Peter and de la Maza, Luis M},
  title = {Presentation of the protective epitope in a Chlamydia muridarum MOMP vaccine is dependent on γ-interferon-inducible lysosomal thiol reductase (GILT)},
  journal = {ImmunoHorizons},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1093/immhor/vlag018}
}
Kostenlos starten →